Shopping Cart
- Remove All
Your shopping cart is currently empty
PF-05221304 (NSC-170984) is an orally active, liver-targeted inhibitor of acetyl-CoA carboxylase (ACC), a rate-limiting enzymes for fatty acid synthesis.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $86 | In Stock | |
| 5 mg | $176 | In Stock | |
| 10 mg | $265 | In Stock | |
| 25 mg | $460 | In Stock | |
| 50 mg | $598 | In Stock | |
| 100 mg | $870 | In Stock | |
| 200 mg | $1,170 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $268 | In Stock |
| Description | PF-05221304 (NSC-170984) is an orally active, liver-targeted inhibitor of acetyl-CoA carboxylase (ACC), a rate-limiting enzymes for fatty acid synthesis. |
| In vitro | PF-05221304 blocked polarization of human T cells to proinflammatory but not anti-inflammatory T cells, and suppressed activation of primary human stellate cells to myofibroblasts in vitro, showing direct effects on inflammation and fibrogenesis[1]. |
| In vivo | PF-05221304 reduced markers of inflammation and fibrosis in the diethylnitrosamine chemical-induced liver injury model and the choline-deficient, high-fat-fed rat model[1]. |
| Synonyms | STAT5 Inhibitor III, R 6238,, NSC 170984, Clesacostat |
| Molecular Weight | 502.56 |
| Formula | C28H30N4O5 |
| Cas No. | 1370448-25-1 |
| Smiles | O=C1CC2(CC3=C1N(C(C)C)N=C3)CCN(C(=O)C=4C=C(N=C(OC)C4)C5=CC=C(C(O)=O)C=C5)CC2 |
| Relative Density. | 1.36 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 95 mg/mL (189.03 mM), Sonication is recommended. Ethanol: 5 mg/mL (9.95 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.